Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

The interactome of a PTB domain-containing adapter protein, Odin, revealed by SILAC.

Zhong J, Chaerkady R, Kandasamy K, Gucek M, Cole RN, Pandey A.

J Proteomics. 2011 Mar 1;74(3):294-303. doi: 10.1016/j.jprot.2010.11.006. Epub 2010 Nov 13.

2.

Cloning of a novel phosphotyrosine binding domain containing molecule, Odin, involved in signaling by receptor tyrosine kinases.

Pandey A, Blagoev B, Kratchmarova I, Fernandez M, Nielsen M, Kristiansen TZ, Ohara O, Podtelejnikov AV, Roche S, Lodish HF, Mann M.

Oncogene. 2002 Nov 14;21(52):8029-36.

3.
4.

Odin (ANKS1A) modulates EGF receptor recycling and stability.

Tong J, Sydorskyy Y, St-Germain JR, Taylor P, Tsao MS, Moran MF.

PLoS One. 2013 Jun 25;8(6):e64817. doi: 10.1371/journal.pone.0064817. Print 2013.

5.

Solution structure of the first Sam domain of Odin and binding studies with the EphA2 receptor.

Mercurio FA, Marasco D, Pirone L, Pedone EM, Pellecchia M, Leone M.

Biochemistry. 2012 Mar 13;51(10):2136-45. doi: 10.1021/bi300141h. Epub 2012 Mar 5.

6.

Mapping the integrin-linked kinase interactome using SILAC.

Dobreva I, Fielding A, Foster LJ, Dedhar S.

J Proteome Res. 2008 Apr;7(4):1740-9. doi: 10.1021/pr700852r. Epub 2008 Mar 10.

PMID:
18327965
7.

A Cortactin-CD2-associated protein (CD2AP) complex provides a novel link between epidermal growth factor receptor endocytosis and the actin cytoskeleton.

Lynch DK, Winata SC, Lyons RJ, Hughes WE, Lehrbach GM, Wasinger V, Corthals G, Cordwell S, Daly RJ.

J Biol Chem. 2003 Jun 13;278(24):21805-13. Epub 2003 Apr 2.

8.

Heterotypic Sam-Sam association between Odin-Sam1 and Arap3-Sam: binding affinity and structural insights.

Mercurio FA, Marasco D, Pirone L, Scognamiglio PL, Pedone EM, Pellecchia M, Leone M.

Chembiochem. 2013 Jan 2;14(1):100-6. doi: 10.1002/cbic.201200592. Epub 2012 Dec 13.

10.

Mouse embryonic fibroblasts derived from Odin deficient mice display a hyperproliiferative phenotype.

Kristiansen TZ, Nielsen MM, Blagoev B, Pandey A, Mann M.

DNA Res. 2004 Aug 31;11(4):285-92.

PMID:
15500253
11.
12.

A novel proteomic screen for peptide-protein interactions.

Schulze WX, Mann M.

J Biol Chem. 2004 Mar 12;279(11):10756-64. Epub 2003 Dec 16.

13.

Screening for PTB domain binding partners and ligand specificity using proteome-derived NPXY peptide arrays.

Smith MJ, Hardy WR, Murphy JM, Jones N, Pawson T.

Mol Cell Biol. 2006 Nov;26(22):8461-74. Epub 2006 Sep 18. Erratum in: Mol Cell Biol. 2007 Jun;27(12):4601.

14.
16.

Identification of novel SH3 domain ligands for the Src family kinase Hck. Wiskott-Aldrich syndrome protein (WASP), WASP-interacting protein (WIP), and ELMO1.

Scott MP, Zappacosta F, Kim EY, Annan RS, Miller WT.

J Biol Chem. 2002 Aug 2;277(31):28238-46. Epub 2002 May 23.

17.

The SAM domains of Anks family proteins are critically involved in modulating the degradation of EphA receptors.

Kim J, Lee H, Kim Y, Yoo S, Park E, Park S.

Mol Cell Biol. 2010 Apr;30(7):1582-92. doi: 10.1128/MCB.01605-09. Epub 2010 Jan 25.

18.
19.

Adaptor proteins intersectin 1 and 2 bind similar proline-rich ligands but are differentially recognized by SH2 domain-containing proteins.

Novokhatska O, Dergai M, Tsyba L, Skrypkina I, Filonenko V, Moreau J, Rynditch A.

PLoS One. 2013 Jul 25;8(7):e70546. doi: 10.1371/journal.pone.0070546. Print 2013.

20.

Dynamic interaction of CD2 with the GYF and the SH3 domain of compartmentalized effector molecules.

Freund C, Kühne R, Yang H, Park S, Reinherz EL, Wagner G.

EMBO J. 2002 Nov 15;21(22):5985-95.

Supplemental Content

Support Center